Remembering Dr. J. Michael Bishop: A Pioneer in Cancer Research

Dr. J. Michael Bishop, a distinguished scientist who shared the Nobel Prize for his groundbreaking work in cancer research, passed away on March 20, 2026, at the age of 90 due to pneumonia. He served as the eighth chancellor of the University of California, San Francisco (UCSF), where he played a pivotal role in expanding the institution. Dr. Bishop joined the UCSF faculty in 1968 and held the titles of professor emeritus and chancellor emeritus. His remarkable career included being one of only two Nobel laureates to serve as chancellor within the University of California system.

New York Times

Dr. Bishop, alongside Dr. Harold E. Varmus, was awarded the 1989 Nobel Prize in Physiology or Medicine for their discovery of oncogenes—genes that, when mutated, can lead to cancer. Their research in the 1970s fundamentally altered the scientific understanding of tumor development, establishing oncogenes as critical factors in cancer progression.

New York Times

Dr. Bishop's early education took place in a two-room schoolhouse in rural Pennsylvania, where he demonstrated exceptional academic abilities. His academic journey led him to be accepted into two Ivy League medical schools, highlighting his brilliance and dedication to science. Throughout his career, Dr. Bishop was not only recognized for his scientific achievements but also for his broad knowledge in literature and art, often incorporating these elements into his lectures.

New York Times

Dr. Joseph Goldstein, a long-time friend and fellow Nobel laureate, praised Dr. Bishop's intellect and humor, stating, “I always appreciated Mike’s brilliance and intellect and breadth of knowledge, not only in science but also in literature and art.” This sentiment reflects the profound impact Dr. Bishop had on his colleagues and the scientific community.

New York Times

While Dr. Bishop's contributions to cancer research are widely celebrated, some critics argue that the focus on oncogenes has overshadowed other important areas of cancer research. This perspective emphasizes the need for a more holistic approach to understanding cancer, suggesting that advancements in treatment should consider a broader range of genetic and environmental factors.

New York Times

• “I always appreciated Mike’s brilliance and intellect and breadth of knowledge, not only in science but also in literature and art,” — Dr. Joseph Goldstein, Nobel Laureate

New York Times

In the wake of Dr. Bishop's passing, the UCSF community and the broader scientific community are expected to honor his legacy through memorials and continued research inspired by his work. Discussions regarding the future of cancer research and the importance of diverse approaches are likely to emerge as a tribute to his contributions.

New York Times